Navigation Links
Angiotech announces completion of Bio-Seal(TM) clinical trial enrolment
Date:6/3/2008

VANCOUVER, June 3 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today announced the completion of U.S. clinical trial enrolment for its novel Bio-Seal lung biopsy track plug.

"Our proprietary Bio-Seal product represents a potentially significant improvement in the technology used to diagnose lung cancer," said Dr. William Hunter, President and CEO of Angiotech. "We look forward to a review of the clinical trial data and are hopeful that the data will demonstrate a considerable reduction in the side effects related to lung biopsy procedures."

Bio-Seal is a novel technology designed to reduce the incidence of post-operative pneumothorax (collapsed lung) in patients who undergo lung biopsy procedures. The technology involves the placement of an expanding hydrogel plug along the biopsy needle track during the procedure, closing off the track to subsequent influx of air into the chest during respiration after the biopsy needle is withdrawn. The seal is airtight and the plug is absorbed into the body after healing of the puncture site has occurred

The primary endpoint of the Bio-Seal study is a reduction in the incidence of pneumothorax in patients undergoing lung biopsy procedures when compared with patients who do not receive the Bio-Seal product. The product has already received CE Mark approval and is available for commercial sale in the EU.

Forward Looking Statements

--------------------------

Statements contained in this press release that are not based on historical fact, including without limitation statements containing the words "believes," "may," "plans," "will," "estimate," "continue," "anticip
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Angiotech appoints Hank McKinnell to its Board of Directors
2. Angiotech to participate in Bank of America Health Care Conference
3. Angiotech Expands Quill(TM) SRS product offering receiving FDA 510(k) approval for smaller size diameters of Quill(TM) SRS PDO
4. Angiotech elects to suspend Vascular Wrap(TM) pivotal clinical trials
5. Angiotechs Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
6. Angiotechs novel 5-FU Central Venous Catheter receives FDA 510(k) clearance
7. Angiotech announces director resignation
8. Angiotech announces commercial launch of Cook Medicals Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
9. Angiotech to participate in Credit Suisse Global Leveraged Finance Conference
10. 960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotechs Novel 5-FU Central Venous Catheter
11. Angiotech to participate in Lehman Brothers Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... PA (PRWEB) October 17, 2014 ... being called upon by health facilities around the ... patients are being treated. Among the many places ... includes Texas Health Presbyterian Hospital Dallas and at ... The state-of-the-art vapor-producing robots have been utilized to ...
(Date:10/17/2014)... The global SWIR market report defines and ... of revenue. This market is valued at $60.1 million ... by 2019, at a CAGR of 10.2% from 2014 ... global SWIR market report, to get an idea of ... of the segmentation of the market, and is supported ...
(Date:10/17/2014)... The North American Knowledge-based/Evidence-based Clinical ... segments the market in North America with analysis ... in North America is expected to reach around ... of 8.1% from 2013 to 2018. , Browse ... clinical decision support system (CDSS) market, to get ...
(Date:10/17/2014)... The Middle East and Africa Location Based Services (LBS) ... Middle East and Africa with analysis and forecast of revenue. ... 2014 to $3,403.1 million by 2019, at a CAGR of ... of the Middle East and Africa Location Based Services (LBS) ... provided. It also provides a glimpse of the market segmentation, ...
Breaking Biology Technology:Bioquell’s Vapor Producing Robots Selected to Combat Ebola in Hospitals Around the World 2Bioquell’s Vapor Producing Robots Selected to Combat Ebola in Hospitals Around the World 3Bioquell’s Vapor Producing Robots Selected to Combat Ebola in Hospitals Around the World 4Bioquell’s Vapor Producing Robots Selected to Combat Ebola in Hospitals Around the World 5Bioquell’s Vapor Producing Robots Selected to Combat Ebola in Hospitals Around the World 6The global SWIR market is expected to reach $97.9 million by 2019 - New Report by MicroMarket Monitor 2The global SWIR market is expected to reach $97.9 million by 2019 - New Report by MicroMarket Monitor 3The North American Knowledge-based/Evidence-based Clinical Decision Support System (CDSS) market is expected to reach around $283.3 million by 2018 - MicroMarket Monitor 2The North American Knowledge-based/Evidence-based Clinical Decision Support System (CDSS) market is expected to reach around $283.3 million by 2018 - MicroMarket Monitor 3The North American Knowledge-based/Evidence-based Clinical Decision Support System (CDSS) market is expected to reach around $283.3 million by 2018 - MicroMarket Monitor 4The North American Knowledge-based/Evidence-based Clinical Decision Support System (CDSS) market is expected to reach around $283.3 million by 2018 - MicroMarket Monitor 5The Middle East and Africa Location Based Services (LBS) market is estimated to reach $3,403.1 million by 2019 - New Report by MicroMarket Monitor 2The Middle East and Africa Location Based Services (LBS) market is estimated to reach $3,403.1 million by 2019 - New Report by MicroMarket Monitor 3The Middle East and Africa Location Based Services (LBS) market is estimated to reach $3,403.1 million by 2019 - New Report by MicroMarket Monitor 4
... a long-term reversal of tinnitus, a debilitating hearing impairment ... up to 40 percent of military veterans, according to ... of Nature . Researchers Dr. Michael ... Texas at Dallas and University-affiliated biotechnology firm MicroTransponder report ...
... success of the previous conferences of the series held ... (EPD) conferences are a leading venue for experts from ... as a processing technique for fabrication of both traditional ... electric surface charge on particles in suspension, which migrate ...
... NEOG ) today announced that its rapid test ... the U.S. Food and Drug Administration (FDA) to be equivalent ... sensitivity for detecting SE. The FDA,s determination of ... Reveal for SE to shorten the testing time and comply ...
Cached Biology Technology:Nature article focuses on tinnitus treatment 2Nature article focuses on tinnitus treatment 34th International Conference on Electrophoretic Deposition 24th International Conference on Electrophoretic Deposition 34th International Conference on Electrophoretic Deposition 4Neogen's Rapid Test for Salmonella enteritidis Receives FDA Approval 2
(Date:10/15/2014)... Oct. 15, 2014 Sandata Technologies, LLC, ... and community-based care, today announced it released a ... Santrax® Electronic Visit Verification™ Solution (EVV™)  for Quality ... home health company founded in 1996 and has ... The study details the challenges ...
(Date:10/15/2014)... The book ,Models of Life, is a non-traditional biophysics ... itself. The book is a journey of discovery into ... of life and biological regulation. It is about how ... strategic communication between the billions of cells in an ... the relationships between principles, which can be found on ...
(Date:10/15/2014)... to an unexpected extent. The outbreak does not follow ... shows a new disease dynamic in regions, where it ... German National Academy of Sciences Leopoldina, acatech – the ... of the German Academies of Sciences and Humanities have ... In the statement the academies call for the following ...
Breaking Biology News(10 mins):Sandata Announces Case Study with Quality Care Services, Inc. 2New book about life as seen from physics 2Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5
... that the amount of health-linked polyphenols present during roasting ... and might be used to limit the generation of ... family of naturally occurring plant components that have been ... Flavonoids and some anti-oxidants belong to the polyphenol family ...
... has shown promise in skin disease and hemophilia might one ... new study by researchers at Stanford University School of Medicine. ... the Proceedings of the National Academy of Sciences the week ... a healthy copy of the gene dystrophin into mice with ...
... and Infectious Diseases (NIAID), part of the National ... drug candidate attacks the bacterium that causes tuberculosis ... the National Academy of Sciences, the finding may ... targets Mycobacterium tuberculosis (M. tb). , "PA-824, ...
Cached Biology News:Chemical compound inhibits tumor growth, size in new mouse study 2Chemical compound inhibits tumor growth, size in new mouse study 3Gene therapy for muscular dystrophy fixes frail muscle cells in animal model, Stanford study finds 2Gene therapy for muscular dystrophy fixes frail muscle cells in animal model, Stanford study finds 3NIAID researchers show how promising TB drug works 2NIAID researchers show how promising TB drug works 3
Capture faint-light images without losing sensitivity or resolution. With its brand new hardware and interface design, the LAS-1000plus turns sample imaging into a simple process....
This pump accomodates StemSep ; pump feed columns of the following sizes : 0.3in., 0.5in., 0.6in., and 1.0in.....
Designed for use with the Agencourt CleanSEQ and Agencourt AMPure 384-well SPRI reagent kits. For use with 384-well thermal cycling plates....
...
Biology Products: